New CEO at Prohealth

Peter Apap, co-founder and director of Prohealth Ltd, has been appointed chief executive officer.

Prohealth has imported and distributed leading pharmaceutical and dermo-cosmetic brands since 1995.

The other co-founders and executive directors John Jaccarini and Andrew Paris have responsibility for export business development, and procurement and regulatory affairs respectively. Joseph FX Zahra, who has been a consultant with Prohealth for the last two years, chairs the board of directors in a non-executive capacity.

The company also announced the appointment of Andrew Spiteri Willets as financial controller.

These changes are aimed at growing the company’s market share in Malta, by consolidation of its brands such as La Roche-Posay, Vichy, Ursapharm and Kin, as well as the introduction of new products, and continued rapid growth of its more recently established medical devices division.

This restructuring will enable Prohealth to embark on a more aggressive drive to develop business in new export markets in addition to its established Libya market.


See our Comments Policy Comments are submitted under the express understanding and condition that the editor may, and is authorised to, disclose any/all of the above personal information to any person or entity requesting the information for the purposes of legal action on grounds that such person or entity is aggrieved by any comment so submitted. Please allow some time for your comment to be moderated.

Comments not loading? We recommend using Google Chrome or Mozilla Firefox with javascript turned on.
Comments powered by Disqus